Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many claimants have successfully been awarded compensation by the Vaccine Damage Payment Scheme since Covid-19 was added to the scheme.
Answered by Maria Caulfield
Between COVID-19 being added to the Vaccine Damage Payment Scheme (VDPS) on 31 December 2020 and 16 January 2024, 163 claimants to the VDPS have received an award for claims in relation to an eligible vaccine, including COVID-19. No claims to the VDPS have received compensation, as the VDPS is not a compensation scheme, and it is not designed to cover all expenses associated with severe disablement.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of the claimants to the Vaccine Damage Payment Scheme for disability caused by the Covid-19 vaccinations received their first vaccine in (a) January to March 2021, (b) April to June 2021 and (c) July to September 2021.
Answered by Maria Caulfield
As of 5 January 2024, of the 8778 COVID-19 related applications to the Vaccine Damage Payment Scheme, 4658 applications or 53.06% related to a first vaccination received between January and March 2021; 2028 applications or 23.10% related to a first vaccination received between April and June 2021; and 516 applications or 5.88% related to a first vaccination received between July and September 2021.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many (a) claims to the Vaccine Damage Payment Scheme for disability caused by the Covid-19 vaccines and (b) applications for mandatory reversals to such claims, have been outstanding for more than (i) 18 months, (ii) 12 months and (iii) six months.
Answered by Maria Caulfield
As of 5 January 2024, of the claims submitted to the Vaccine Damage Payment Scheme relating to COVID-19, 157 claims have been outstanding for more than 18 months; 341 claims have been outstanding for over 12 months and 1854 claims have been outstanding for over six months.
Of these claims, no mandatory reversals have been submitted that have been outstanding for over 18 months; 18 mandatory reversal applications have been outstanding for over 12 months, and 124 mandatory reversal applications have been outstanding for over six months.
Jul. 17 2024
Source Page: Main Supply Estimates 2024 to 2025Found: Expenditure incurred in relation to the Covid-19 Vaccine Taskforce.
Jul. 17 2024
Source Page: Main Supply Estimates 2024 to 2025Found: Expenditure incurred in relation to the Covid-19 Vaccine Taskforce.
Jan. 25 2024
Source Page: UKHSA annual report and accounts: 2022 to 2023Found: UKHSA aimed to minimise adverse outcomes such as harm, loss or damage to the organisation, its people
Jan. 25 2024
Source Page: UKHSA annual report and accounts: 2022 to 2023Found: UKHSA aimed to minimise adverse outcomes such as harm, loss or damage to the organisation, its people
Jan. 25 2024
Source Page: UKHSA annual report and accounts: 2022 to 2023Found: UKHSA aimed to minimise adverse outcomes such as harm, loss or damage to the organisation, its people
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer- BioNTech Coronavirus
Oral Evidence Feb. 28 2024
Inquiry: Emerging diseases and learnings from covid-19Found: so I assume that you cannot simply keep people on permanently without a contract—in other words, payment